Modular anti‐EGFR and anti‐Her2 targeting of SK‐BR‐3 and BT474 breast cancer cell lines in the presence of ErbB receptor‐specific growth factors
Simone Diermeier‐Daucher(Zero to Three), Gero Brockhoff(University of Regensburg)
Cited by 35
Related Papers
Humanized tumor mice—A new model to study and manipulate the immune response in advanced cancer therapy
|International Journal of Cancer|2011|105
Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer
|British Journal of Cancer|2012|59
HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women
|Breast Cancer Research|2018|19